Back

Patients without conventional modifiable risk factors (SMuRFless) presenting with obstructive myocardial infarction face a significantly higher 30-day mortality

30 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Biomarkers and assessing outcomes in coronary artery disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Sina Fathieh

Hammersmith Hospital, London (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor S. Swieszkowski (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Doctor J. Costabel (Buenos Aires, AR)
Abstract
Presentation thumbnail
Doctor H. Wada (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Professor L. Rallidis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Biomarkers and assessing outcomes in coronary artery disease

The Event

Event poster

ESC Congress 2025

30 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Standard modifiable risk factors (SMuRF) paradox for the prognosis in the patients with acute myocardial infarction
thumbnail
Congress Presentation
Standard modifiable risk factors and mortality in patients with ST-segment elevation myocardial infarction: findings from the FRENCHIE cohort.
thumbnail
Congress Presentation
Prevalence and outcomes of acute coronary syndrome patients with and without standard modifiable risk factors undergoing percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources